MIRA Trademark

Trademark Overview

On Monday, September 14, 2020, a trademark application was filed for MIRA with the United States Patent and Trademark Office. The USPTO has given the MIRA trademark a serial number of 90178980. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Sunday, July 21, 2024. This trademark is owned by QUARK BIOSCIENCES TAIWAN, INC.. The MIRA trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical evaluation of endometrial receptivity by determining and analyzing the expression level of microRNAs in bodily fluid and tissue samples
mira

General Information

Serial Number90178980
Word MarkMIRA
Filing DateMonday, September 14, 2020
Status653 - SUSPENSION LETTER - MAILED
Status DateSunday, July 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedical evaluation of endometrial receptivity by determining and analyzing the expression level of microRNAs in bodily fluid and tissue samples

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 21, 2020
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameINTI TAIWAN, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressZHUBEI CITY, HSINCHU COUNTY 302041
TW
Party NameQUARK BIOSCIENCES TAIWAN, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressZhubei City, Hsinchu 302058
TW

Trademark Events

Event DateEvent Description
Thursday, September 17, 2020NEW APPLICATION ENTERED
Wednesday, October 21, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 3, 2021NON-FINAL ACTION E-MAILED
Tuesday, January 26, 2021ASSIGNED TO EXAMINER
Wednesday, February 3, 2021NON-FINAL ACTION WRITTEN
Wednesday, February 3, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, August 1, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, August 1, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 2, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 20, 2021NON-FINAL ACTION E-MAILED
Wednesday, August 18, 2021ASSIGNED TO EXAMINER
Monday, September 20, 2021NON-FINAL ACTION WRITTEN
Monday, September 20, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 18, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 18, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 18, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 15, 2022SUSPENSION LETTER WRITTEN
Tuesday, February 15, 2022LETTER OF SUSPENSION E-MAILED
Tuesday, February 15, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, August 22, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, March 29, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, March 24, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, March 27, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, June 24, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 24, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 24, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, July 21, 2024LETTER OF SUSPENSION E-MAILED
Sunday, July 21, 2024SUSPENSION LETTER WRITTEN
Sunday, July 21, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, April 16, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 26, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, September 27, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, April 16, 2024NON-FINAL ACTION WRITTEN
Tuesday, April 16, 2024NON-FINAL ACTION E-MAILED

Related Keywords

mira bodily micrornas fluid tissue samples level expression endometrial evaluation receptivity